Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
NURSING , CAREGIVER , HOTEL & BEAUTY COURSES
IVA Para Medical Campus
Updated:
Today at 9:24 AM
Handmade Character Soft Toys Peppa Pig Family
anil1961
Updated:
Yesterday at 9:58 PM
Ad icon
Video Content Creator
pramukag
Updated:
Sunday at 6:10 AM
Ad icon
QA Engineer Intern
pramukag
Updated:
Sunday at 6:07 AM
Ad icon
Sell your Land, House on idamata.lk for FREE
sajith.xp.pk
Updated:
Jun 25, 2026
Electronics
Vehicles
Property
Search
Reply to thread
Forums
ElaKiri.com
News and Updates
Moderna comments on the emerging Covid variants
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="imhotep" data-source="post: 26089302" data-attributes="member: 562115"><p>According to Moderna, their COVID-19 vaccine is still effective against the SARS-CoV-2 variants, B.1.1.7 and B.1.351, which scientists first identified in the United Kingdom and South Africa, respectively. However, the vaccine had a significantly reduced antibody response to the latter.</p><p></p><p>The researchers used sera from individuals who had received the Moderna vaccine, and they found no significant impact on antibody response to the B.1.1.7 variant. Although there was a six-fold reduction in antibody response to the B.1.351 variant, but they explain that the antibodies “remain above levels that we expect to be protective.”</p><p></p><p>Moderna are already testing a booster vaccine candidate that specifically targets the spike proteins of the B.1.351 variant.</p></blockquote><p></p>
[QUOTE="imhotep, post: 26089302, member: 562115"] According to Moderna, their COVID-19 vaccine is still effective against the SARS-CoV-2 variants, B.1.1.7 and B.1.351, which scientists first identified in the United Kingdom and South Africa, respectively. However, the vaccine had a significantly reduced antibody response to the latter. The researchers used sera from individuals who had received the Moderna vaccine, and they found no significant impact on antibody response to the B.1.1.7 variant. Although there was a six-fold reduction in antibody response to the B.1.351 variant, but they explain that the antibodies “remain above levels that we expect to be protective.” Moderna are already testing a booster vaccine candidate that specifically targets the spike proteins of the B.1.351 variant. [/QUOTE]
Insert quotes…
Verification
Hath warak paha keeyada? (hatha wadikireema paha)
Post reply
Top
Bottom